Reply to Fredrik Liedberg, Johan Abrahamsson, and Johannes Bobjer’s Letter to the Editor re: Keisuke Shigeta, Kazuhiro Matsumoto, Koichiro Ogihara, et al. Does Neoadjuvant Chemotherapy have Therapeutic Benefit for Node-positive Upper Tract Urothelial Carcinoma? Results of a Multi-center Cohort Study. Urol Oncol. In press. https://doi.org/10.1016/j.urolonc.2021.07.029: A Plea for Uniform Terminology for Patients with Urothelial Carcinoma Treated with Chemotherapy Before Consolidative Surgery with

Reply to Fredrik Liedberg, Johan Abrahamsson, and Johannes Bobjer’s Letter to the Editor re: Keisuke Shigeta, Kazuhiro Matsumoto, Koichiro Ogihara, et al. Does Neoadjuvant Chemotherapy have Therapeutic Benefit for Node-positive Upper Tract Urothelial Carcinoma? Results of a Multi-center Cohort Study. Urol Oncol. In press. https://doi.org/10.1016/j.urolonc.2021.07.029: A Plea for Uniform Terminology for Patients with Urothelial Carcinoma Treated with Chemotherapy Before Consolidative Surgery with

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European urology 2022-01, Vol.81 (1), p.e20-e21
Hauptverfasser: Shigeta, Keisuke, Matsumoto, Kazuhiro, Oya, Mototsugu
Format: Artikel
Sprache:eng
Schlagworte:
Carcinoma, Transitional Cell - drug therapy
Cohort Studies
Female
Humans
Male
Neoadjuvant Therapy
Urinary Bladder Neoplasms - pathology
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:
ISSN:0302-2838
1873-7560
DOI:10.1016/j.eururo.2021.10.008